E-LIB Suche - Ergebnisse für: Kumar, Sushma

1

Molnupiravir: Mechanism of action, clinical, and translatio..:

Maas, Brian M. ; Strizki, Julie ; Miller, Randy R....
Clinical and Translational Science. 17 (2024) 2 - p. , 2024

Link: https://doi.org/10.1111/..

2

Safety and efficacy of doravirine as first-line therapy in ..:

Orkin, Chloe ; Molina, Jean-Michel ; Cahn, Pedro...
The Lancet HIV. 11 (2024) 2 - p. e75-e85 , 2024

Link: https://doi.org/10.1016/..

3

626. The Efficacy and Safety of Maintenance with Doravirine..:

Cahn, Pedro ; Molina, Jean-michel ; Lombaard, Johan...
Open Forum Infectious Diseases. 8 (2021) Supplement_1 - p. S417-S417 , 2021

Link: https://doi.org/10.1093/..

4

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (TDF) V..:

Orkin, Chloe ; Squires, Kathleen E ; Molina, Jean-Michel...
Clinical Infectious Diseases. , 2020

Link: https://doi.org/10.1093/..

5

Review of Doravirine Resistance Patterns Identified in Part..:

Martin, Elizabeth Anne ; Lai, Ming-Tain ; Ngo, Winnie...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 85 (2020) 5 - p. 635-642 , 2020

Link: https://doi.org/10.1097/..

6

Once-daily Doravirine in Human Immunodeficiency Virus Type ..:

Hwang, Carey ; Hanna, George ; Martin, Elizabeth...
Clinical Infectious Diseases. 70 (2019) 7 - p. 1344-1352 , 2019

Link: https://doi.org/10.1093/..

7

Once-daily Doravirine for Initial Treatment of Adults Livin..:

Thompson, Melanie ; Orkin, Chloe ; Molina, Jean-Michel...
Clinical Infectious Diseases. , 2019

Link: https://doi.org/10.1093/..

8

Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fum..:

Johnson, Margaret ; Kumar, Princy ; Molina, Jean-Michel...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 81 (2019) 4 - p. 463-472 , 2019

Link: https://doi.org/10.1097/..

9

Efficacy and Safety of Doravirine/Lamivudine/Tenofovir Diso..:

Wong, Alexander ; Goldstein, Deborah ; Mallolas, Josep...
JAIDS Journal of Acquired Immune Deficiency Syndromes. 82 (2019) 4 - p. e47-e49 , 2019

Link: https://doi.org/10.1097/..

10

LB2. Switch to Doravirine/Lamivudine/Tenofovir Disoproxil F..:

Kumar, Princy ; Johnson, Margaret ; Molina, Jean-Michel...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S759-S760 , 2018

Link: https://doi.org/10.1093/..

11

543. An Integrated Safety Analysis Comparing Once-Daily Dor..:

Thompson, Melanie ; Orkin, Chloe ; Molina, Jean-Michel...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S201-S202 , 2018

Link: https://doi.org/10.1093/..

12

Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate is Non-..:

Orkin, Chloe ; Squires, Kathleen E ; Molina, Jean-Michel...
Clinical Infectious Diseases. 68 (2018) 4 - p. 535-544 , 2018

Link: https://doi.org/10.1093/..

13

LB1. Doravirine/Lamivudine/Tenofovir DF Continues to Be Non..:

Orkin, Chloe ; Squires, Kathleen ; Molina, Jean-Michel...
Open Forum Infectious Diseases. 5 (2018) suppl_1 - p. S759-S759 , 2018

Link: https://doi.org/10.1093/..

14

Doravirine dose Selection and 96-Week Safety and Efficacy v..:

Gatell, Jose M ; Morales-Ramirez, Javier O ; Hagins, Debbie P...
Antiviral Therapy. 24 (2018) 6 - p. 425-435 , 2018

Link: https://doi.org/10.3851/..

15

Incidence of HBV Infection in Pregnent Female at a Tertiary..:

Sinha, Ajitkr ; Singh, Anant ; Kumar, Sushma
Journal of Clinical and Experimental Hepatology. 4 (2014) - p. S12-S13 , 2014

Link: https://doi.org/10.1016/..